Simone Gold, who advocated hydroxychloroquine as a remedy for coronavirus, arrested in connection to Capitol "riot"
(Natural News) The left-wing media is having a heyday with the news that America’s Frontline Doctors head Dr. Simone Gold was arrested for having appeared at the United States Capitol on Jan. 6. Dr. Gold was present with her megaphone to deliver a speech about the dangers and ineffectiveness of Wuhan coronavirus (COVID-19) vaccines, urging... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2021 Category: Consumer Health News Source Type: news

Pustulosis, Stevens-Johnson Syndrome Due to Hydroxychloroquine Pustulosis, Stevens-Johnson Syndrome Due to Hydroxychloroquine
This case draws attention to the possibility of severe adverse cutaneous drug reactions to hydroxychloroquine and the necessity for caution when using hydroxychloroquine to manage COVID-19.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 20, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report, European Journal of Hospital Pharmacy
Portuguese study reported a greater incidence of adverse drug reactions with hydroxychloroquine vs remdesivir (n=149; total of 102 events; 47.5% vs 12.5%; p (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 19, 2021 Category: Consumer Health News Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels>1,068 versus
Source: The Doctors Lounge - Oncology - January 11, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pathology, Pharmacy, Rheumatology, Journal, Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
MONDAY, Jan. 11, 2021 -- For patients with systemic lupus erythematosus (SLE), lower hydroxychloroquine (HCQ) blood levels are associated with a higher risk for thrombotic events, according to a study published online Jan. 5 in Arthritis&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Hydroxychloroquine blood levels predict clotting risk in patients with lupus
(Wiley) A new study in Arthritis& Rheumatology shows that monitoring patients' blood levels of hydroxychloroquine can predict their clotting risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study - Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Areia C, Biedermann P, Banda JM, Burn E, Casajust P, Fister K, Hardin J, Hester L, Hripcsak G, Kaas-Hansen BS, Khosla S, Kolovos S, Lynch KE, Makadia R, Mehta PP, Morales DR, Morgan-Stewart H, Mosseveld M, Newby D, Nyberg F, Ostropolets A, Woong Park R, Prats-Uribe A, Rao GA, Reich C, Rijnbeek P, Sena AG, Shoaibi A, Spotnitz M, Vignesh S, Suchard MA, Vizcaya D, Wen H, de Wilde M, Xie J, You SC, Zhang L, Lovestone S, Ryan P, Prieto-Alhambra D.
OBJECTIVES: Concern has been raised in the rheumatology community regarding recent regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute psychiatric events. We aimed to study whether there is risk of incident depre... (Source: SafetyLit)
Source: SafetyLit - December 31, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Pharmaceutical factory that manufactures hydroxychloroquine mysteriously bursts into flames, explodes
(Natural News) On Dec. 20, an SCI Pharmtech manufacturing facility in Taoyuan City, Taiwan, burst into flames and exploded, leaving two people injured. The facility, which manufactures the anti-Wuhan coronavirus (COVID-19) drug hydroxychloroquine, appears to have been targeted, perhaps by COVID-19 vaccine interests, in an effort to punish the company for manufacturing the inexpensive, highly... (Source: NaturalNews.com)
Source: NaturalNews.com - December 24, 2020 Category: Consumer Health News Source Type: news

WHO publishes updated living guideline on therapeutics and Covid-19, WHO
Based on the results of a systematic review and meta-analysis, the guideline panel makes new strong recommendations against the use of hydroxychloroquine and lopinavir/ritonavir in patients with Covid-19, regardless of disease severity. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 21, 2020 Category: Consumer Health News Source Type: news

Physician Indicted for Selling Hydroxychloroquine as COVID Cure Physician Indicted for Selling Hydroxychloroquine as COVID Cure
The doctor faces up to 20 years in prison on allegations of fraudulently obtaining hydroxychloroquine and selling it with other drugs in anti-COVID-19 kits.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 18, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Doctor Selling COVID-19 “Cure” Charged with Lying to U.S. Customs, Stealing Employee’s Identity
FDA OCI, Jennings Staley M.D., COVID-19, coronavirus, hydroxychloroquine, miracle cure, treatment kit, Chinese supplier, smuggle, Skinny Beach Med Spa, mail fraud, identity theft, bogus Rx, magic bullet, 100% effective cure, sham, bogus, prescription, yam extract, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 11, 2020 Category: Medical Law Authors: DOJ Source Type: news

Doctor Selling COVID-19 “Cure” Charged with Lying to U.S. Customs, Stealing Employee’s Identity
FDA OCI, Jennings Staley MD, charged, lying, miracle cure, Skinny Beach Med Spas, COVID-19, coronavirus, smuggle, hydroxychloroquine, treatment kit, mefloquine, "Russian cure", China, suppliers, San Diego, mail fraud, employee identity, stolen, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 7, 2020 Category: Medical Law Authors: DOJ Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) 1. Hydroxychloroquine shows no benefit for postexposure prophylaxis for preventing SARS-CoV-2 infection ; 2. Patients with COVID-19 may develop an array of symptoms that evolve over time ; 3. Wuhan study helps researchers better understand SARS-CoV-2 positivity and the disease course of COVID-19 ; 4. Simultaneous COVID-19 infection in identical twins helps to explain differences in illness severity ; 5. Caring for dying patients during the pandemic shows the human side of medicine (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 7, 2020 Category: Infectious Diseases Source Type: news

Anti-Vaccine Doctor Has Been Invited to Testify Before Senate Committee
The selection of Dr. Jane M. Orient as federal health officials are trying to promote a vaccine to end the coronavirus pandemic prompted harsh criticism from Senator Chuck Schumer, Democrat of New York. (Source: NYT Health)
Source: NYT Health - December 7, 2020 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Orient, Jane M. Senate Committee on Homeland Security and Governmental Affairs Coronavirus (2019-nCoV) Vaccination and Immunization Hydroxychloroquine (Drug) Conspiracy Theories Assn of American Physicians and Surgeons United States Politics Source Type: news

Antiviral Drugs Have No Effect on Mortality in COVID - 19
Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in - hospital mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 4, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Antiviral Drugs Have No Effect on Mortality in COVID-19
FRIDAY, Dec. 4, 2020 -- For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have little to no effect on mortality, according to a study published online Dec. 2 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 4, 2020 Category: Pharmaceuticals Source Type: news

Analysis finds four repurposed antiviral drugs have little or no effect on patients hospitalised for COVID-19
Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little or no effect on patients hospitalised for the disease, in terms of overall mortality, initiation of ventilation and duration of hospital stay. The interim findings from the WHO Solidarity trial, published in the New England Journal of Medicine (NEJM), followed 11,266 adults at 405 hospitals in 30 countries. (Source: University of Bristol news)
Source: University of Bristol news - December 4, 2020 Category: Universities & Medical Training Tags: Research, International, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Systemic Lupus Erythematosus Abstracts From ACR Convergence Systemic Lupus Erythematosus Abstracts From ACR Convergence
Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including the effects of hydroxychloroquine on QTc length and use of belimumab and obinutuzumab on renal outcomes.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

US Presidential Election Part 3: President Trump ’s Legacy of Mismanagement of the Pandemic
Credit: Whitehouse.GovBy Farhang JahanpourOXFORD, Dec 1 2020 (IPS) Covid-19 is on track to be the deadliest and one of the most catastrophic epidemics since the 1918-1919 flu pandemic, which infected about 500 million people or one-third of the world’s population at the time. The number of deaths was estimated somewhere between 17 and 50 million, and possibly as high as 100 million worldwide. The first observations of illness and mortality were documented in December 1917 at Camp Greene, North Carolina. To maintain morale, World War I censors minimized reports of casualties, but as newspapers in neutral Spain were f...
Source: IPS Inter Press Service - Health - December 1, 2020 Category: International Medicine & Public Health Authors: Farhang Jahanpour Tags: Democracy Global Geopolitics Headlines Health North America TerraViva United Nations Source Type: news

Update to information on psychiatric disorders for chloroquine and hydroxychloroquine, EMA
EMA's safety committee (PRAC) has recommended updating product information for all chloroquine or hydroxychloroquine-containing medicines following a review that confirmed a link between the use of these medicines and the risk of psychiatric disorders and suicidal behaviour. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2020 Category: Consumer Health News Source Type: news

Rutgers leading coronavirus therapeutic clinical trial
(Rutgers University) Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Mechanism of action of chloroquine/hydroxychloroquine for COVID-19 infection
(Bentham Science Publishers) The recent serious outbreak of Covid19 has required urgent medical treatments for numerous patients. No clinically active vaccines or antiviral agents are available for Covid19. According to several studies, Chloroquine (CQ) and Hydroxychloroquine (HCQ) have shown promises as Covid19 antiviral especially when administered with Azithromycin (AZM). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

COVID-19: A data challenge and a catalyst for new insights
  One of the key issues that arose during the pandemic, and arguably a factor that has led to more deaths, has been one of healthcare systems, public health and governments having insufficient or no relevant data on which to base critical decisions. The right data are not in the right place to answer the right questions at the right time. Yet, in the midst of this we have also seen remarkable collaboration on the scientific response to the pandemic, from diagnostics to therapeutic and vaccine research and development. We have learned a lot about the virus since its genome was shared by Chinese researchers in Jan...
Source: EyeForPharma - November 24, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Hydroxychloroquine doesn ’t benefit hospitalized COVID-19 patients
In a final analysis of study data, researchers concluded that the medication hydroxychloroquine provides no benefit to adults hospitalized with COVID-19. (Source: NIH Research Matters)
Source: NIH Research Matters - November 23, 2020 Category: Research Source Type: news

New insight into the effect of hydroxychloroquine undermines its use in COVID-19
(Radboud University Medical Center) Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. It inhibits the action of a type of white blood cells important in the first line of defense against infections. Based on this research, hydroxychloroquine is unlikely to be beneficial in clearing viral infections including the new coronavirus SARS-CoV-2, they write in their publication inCell Reports Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 23, 2020 Category: Infectious Diseases Source Type: news

Methotrexate and HCQ Split on Cardiovascular Outcomes in RA Methotrexate and HCQ Split on Cardiovascular Outcomes in RA
No significant differences in major adverse cardiovascular events emerged between methotrexate and hydroxychloroquine treatment in a comparison of adults 65 years or older with rheumatoid arthritis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 13, 2020 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
(Vanderbilt University Medical Center) Findings from a national study published today in the Journal of the American Medical Association (JAMA) " do not support " the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 13, 2020 Category: Infectious Diseases Source Type: news

Coronavirus live news: quarter of deaths in France linked to Covid as US tops 140,000 daily cases
France ’s lockdown extended by two weeks; German infection surge may be easing; Russia says its Sputnik-V vaccine is 92% effectiveScientist behind BioNTech/Pfizer vaccine says it can end pandemicBillionaire Trump donors contract Covid after playing down risksCovid infections in Sweden surge, dashing hopes of herd immunityFrench professor faces disciplinary case over hydroxychloroquine claims1.04amGMTOne of the first cruise ships to ply throughCaribbean waters since the pandemic began ended its trip early after five passengers tested positive for Covid-19.The SeaDream is carrying 53 passengers and 66 crew, with the ma...
Source: Guardian Unlimited Science - November 13, 2020 Category: Science Authors: Helen Sullivan Tags: Coronavirus World news Europe UK news US news Science Infectious diseases Source Type: news

French professor faces disciplinary case over hydroxychloroquine claims
Didier Raoult stands accused of touting drug as a coronavirus treatment without evidence (Source: Reuters: Health)
Source: Reuters: Health - November 12, 2020 Category: Consumer Health News Source Type: news

NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19
THURSDAY, Nov. 12, 2020 -- Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute (NHLBI) and published online Nov. 9 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 12, 2020 Category: Pharmaceuticals Source Type: news

French professor faces disciplinary case over hydroxychloroquine claims
Didier Raoult stands accused of touting drug as a coronavirus treatment without evidenceA French professor who touts the anti-malaria drug hydroxychloroquine as a coronavirus treatment – without evidence, scientists say – will appear before a disciplinary panel charged with ethics breaches, an order of doctors has said.Marseille-basedDidier Raoult stands accused by his peers of spreading false information about the benefits of the drug. His promotion of hydroxychloroquine wastaken up by the US and Brazilian presidents, Donald Trump and Jair Bolsonaro, who trumpeted its unproven benefits in a way critics say put...
Source: Guardian Unlimited Science - November 12, 2020 Category: Science Authors: Agence France-Presse in Marseille Tags: France Coronavirus Europe Infectious diseases Science Medical research World news Health Drugs Microbiology Source Type: news

Study: Hydroxychloroquine no better than placebo for hospitalized COVID-19 patients
COVID-19 patients treated with hydroxychloroquine showed no signs of significant improvement in " clinical status " compared with those given a placebo, a study published Monday by JAMA found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 9, 2020 Category: Consumer Health News Source Type: news

Joe Biden and Kamala Harris Announce Their COVID-19 Advisory Board
On Nov. 9, the Biden-Harris transition team announced the members of its COVID-19 advisory board, and met with them for several hours in a virtual conference before President-elect Joe Biden made remarks stressing the importance of mask wearing as a continued “weapon” in the fight against COVID-19. “As we work toward a safe and effective vaccine, the single most effective way to stop the spread of COVID-19: wear a mask,” Biden said, as he held up his own mask. “The head of the CDC [Centers for Disease Control] warned this fall that for the foreseeable future, a mask remains the most potent wea...
Source: TIME: Health - November 9, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Hydroxychloroquine does not treat COVID-19, NIH 'formally' declares
After 14 days, more hospitalized coronavirus patients treated with hydroxychloroquine had died than had those who got a placebo. By 28 days, rates were about the same, the NIH trial found. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine does not benefit adults hospitalized with COVID-19
The trial began after lab studies and preliminary reports suggested that hydroxychloroquine might have promise in treating SARS-CoV-2. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 9, 2020 Category: American Health Source Type: news

Effect of hydroxychloroquine on clinical status
(JAMA Network) This randomized trial compares the effects of hydroxychloroquine versus placebo on patients' clinical status at 14 days (home, requiring noninvasive or invasive ventilation or extracorporeal membrane oxygenation, hospitalized, died) among adults hospitalized with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 9, 2020 Category: Infectious Diseases Source Type: news

Chloroquine Prescribing Patterns for COVID-19 by Specialty Chloroquine Prescribing Patterns for COVID-19 by Specialty
This report reveals that new prescriptions by specialists who don't typically prescribe hydroxychloroquine or chloroquine increased nearly 80-fold during the initial months of the COVID-19 pandemic.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2020 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

COVID-19-Related HCQ Shortages Affected Rheum Patients Worldwide COVID-19-Related HCQ Shortages Affected Rheum Patients Worldwide
Supplies were diverted for COVID when hydroxychloroquine was hyped, without good evidence, as a treatment. In some parts of the world more than 1 in 4 with autoimmune diseases could not get medicines.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 6, 2020 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Doc Who Used Hydroxychloroquine Met Standard of Care; More Doc Who Used Hydroxychloroquine Met Standard of Care; More
Doctor who treated COVID patients met standard of care, officials say; VA settles multiple wrongful-death suits; attorney charged with trying to scam hospital system.Medscape Business of Medicine (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - November 3, 2020 Category: Pharmaceuticals Tags: Family Medicine/Primary Care News Source Type: news

States Want to Approve COVID-19 Vaccines Themselves. Will That Lead to More Trust —Or Less?
Getting a COVID-19 vaccine—and fast—has been a main focus in the fight against the coronavirus. But when a vaccine is ultimately made available to the American public, California Governor Gavin Newsom said at a press conference last week, another factor will come into play: what he called the “speed of trust.” “You have to have confidence in the efficacy of the vaccine, confidence that we’re not rushing to judgment in terms of its distribution and its accessibility,” said Newsom. His comments came while announcing that his state is convening a scientific review panel to double-chec...
Source: TIME: Health - October 30, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

U.S. COVID-19 Cases Are Skyrocketing, But Deaths Are Flat —So Far. These 5 Charts Explain Why
In just the last two weeks, the global daily tally for new COVID-19 cases has jumped more than 30%, according to TIME’s coronavirus tracker, which compiles data from Johns Hopkins University. The steep upward trend is driven by viral waves in Europe and the United States that started in August and mid-September, respectively. On Oct. 23, the daily case count in the U.S. reached a new record high, suggesting that this wave will be worse than the one that swept the country over the summer. But despite this rapid uptick in cases, the daily death count in the U.S. is not yet rising at the same rate, and remains at lower ...
Source: TIME: Health - October 26, 2020 Category: Consumer Health News Authors: Emily Barone Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
(University of Minnesota) University of Minnesota Medical School researchers found that taking hydroxychloroquine once or twice weekly did not prevent the development of COVID-19 in health care workers better than the placebo. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 21, 2020 Category: Infectious Diseases Source Type: news

What the Conflicting Results on Promising COVID-19 Drug Remdesivir Really Mean
Treating any infectious disease is a high wire act—doctors must balance the risks and benefits of therapies with the risks of the disease. And those stakes are even higher for a new disease that doesn’t yet have a playbook for physicians to follow. This summer, the U.S. Food and Drug Administration gave the drug remdesivir emergency use authorization for treating any patients hospitalized with COVID-19. But on Oct.15, researchers working on the World Health Organization’s (WHO) Solidarity trial published a preliminary report showing that nearly 3,000 people receiving the treatment were not more likely to ...
Source: TIME: Health - October 19, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patients
A clinical trial conducted by the World Health Organization found that Gilead Sciences Inc.'s remdesivir, hydroxychloroquine, AbbVie's... (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Remdesivir has 'little effect' on death risks, says WHO
The WHO's 11,266-person trial found no significant reduction in mortality risks among hospitalized COVID-19 patients treated with remdesivir, lopinavir, interferon or hydroxychloroquine (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2020 Category: Consumer Health News Source Type: news

Chinese virologist whistleblower supports Dr. Zelenko’s hydroxychloroquine efforts
(Natural News) A virologist and whistleblower who fled China for her own safety is backing up a New York doctor who has come under attack for trying to spread the word about the efficacy of a hydroxychloroquine triple treatment he has been using to fight coronavirus in patients at his private practice. Chinese virologist Dr.... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does
(KU Leuven) Virologists from the KU Leuven Rega Institute in Belgium have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. The team published their findings in the Proceedings of the National Academy of Sciences (PNAS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 9, 2020 Category: International Medicine & Public Health Source Type: news

Lopinavirritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, The Lancet
Summary Background Lopinavir –ritonavir has been proposed as a treatment for COVID-19 on the basis of in vitro activity, preclinical studies, and observational studies. Here, we report the results of a randomised trial to assess whether lopinavir–ritonavir improves outcomes in patients admitted to hospital with COVID-19. M ethods In this randomised, controlled, open-label, platform trial, a range of possible treatments was compared with usual care in patients admitted to hospital with COVID-19. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients were randomly allocated to either u...
Source: Current Awareness Service for Health (CASH) - October 6, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
TUESDAY, Oct. 6, 2020 -- Hydroxychloroquine administered for eight weeks as preexposure prophylaxis has no clinical benefit in hospital-based health care workers (HCWs) exposed to patients with COVID-19, according to a study published online Sept.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 6, 2020 Category: Pharmaceuticals Source Type: news

What to Know About Sean Conley, the White House Physician
Dr. Conley, who was appointed as President Trump ’s physician in 2018, is a doctor of osteopathic medicine. (Source: NYT Health)
Source: NYT Health - October 4, 2020 Category: Consumer Health News Authors: Allyson Waller and Christina Morales Tags: Trump Coronavirus Positive Result Hydroxychloroquine (Drug) United States Politics and Government Coronavirus (2019-nCoV) Reed, Walter, National Military Medical Center Conley, Sean Patrick Trump, Donald J Jackson, Ronny L Source Type: news